By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka
Read more
antibody
Alpaca nanobodies effective against South African SARS-CoV-2 variant
Researchers in South Africa and the UK have identified alpaca-derived nanoantibodies that potently neutralize variants of the novel severe acute
Read more
purchase evista rx on line
During the acute phase of the COVID-19 pandemic, emergency department doctors, nurses and other frontline staff experienced unprecedented levels of
Read more
Evidence of monoclonal antibodies effectively neutralizing SARS-CoV-2 variants
Evolving variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become a growing concern worldwide for their rapid transmission
Read more
New mRNA COVID-19 vaccine candidate shows promise in vivo
Researchers report that a new lipid nanoparticle mRNA coronavirus disease 2019 (COVID-19) vaccine candidate protected 70% of mice expressing the
Read more
Infliximab may hinder the effectiveness of some COVID-19 vaccines
As many countries are being hit hard by repeated waves of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, with
Read more
Linear epitope mapping of the SARS-CoV-2 spike protein
The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the primary target of many drug discovery
Read more
Most cancer patients with COVID-19 produce antibodies at a rate comparable to general population
Most people with cancer who are infected by the novel coronavirus produce antibodies at a rate comparable to the rest
Read more
Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19
A recent study, currently available on the bioRxiv* preprint server, indicates that a pair of dual-action monoclonal antibodies derived from
Read more
Antibodies to SARS-CoV-2 spike protein and RBD detected in saliva of mRNA-vaccine recipients
Vaccines are very important in controlling the coronavirus disease 2019 (COVID-19) pandemic. Two highly effective mRNA vaccines are available in
Read more